India  

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Video Credit: Wochit - Duration: 00:26s - Published
Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.

He explained "According to the most likely scenario, we will not have a vaccination before the end of next year." Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.

An antibody test, which could be available as early as May, would determine whether someone has had the COVID-19 infection.

If so, they would have assumed ongoing immunity to the virus.

Schwan said that an antibody test is key to allowing businesses to reopen and for people to gradually return to normal life.


You Might Like

Related news from verified sources

Drug touted by Trump to treat COVID-19 linked to higher death risk: study

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking...
Reuters India - Published

WHO halts hydroxychloroquine trials after study shows drug may increase risk of death

"The authors reported that among patients receiving the drug, when used alone or with a macrolide,...
DNA - Published

U.S. veterans agency has given hydroxychloroquine to 1,300 coronavirus patients

The U.S. Department of Veterans Affairs (VA) has treated 1,300 coronavirus patients with the malaria...
Reuters India - Published


Related videos from verified sources

Study focuses on risks of breast cancer after pre-invasive disease [Video]

Study focuses on risks of breast cancer after pre-invasive disease

In a breakthrough study, researchers found that the women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast..

Credit: ANI     Duration: 01:12Published
Study: As COVID-19 Progresses, 40% May Not Show Any Symptoms At All [Video]

Study: As COVID-19 Progresses, 40% May Not Show Any Symptoms At All

A small analysis of 78 COVID-19 patients in China revealed as many as 40% of patients may be asymptomatic. COVID-19 is the disease caused by the novel coronavirus SARS-CoV-2, and is at pandemic levels..

Credit: Wochit     Duration: 00:42Published
WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 [Video]

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 The move comes after a report linked the drug to an increased fatality rate among those with coronavirus. The study in medical journal 'The..

Credit: Wibbitz Top Stories     Duration: 01:30Published